Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,860.00
+105.00 (2.21%)
At close: Jun 4, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 53.66 billion as of June 5, 2026. Its market cap has decreased by -10.00% in one year.
Market Cap
53.66B
Enterprise Value
44.78B
Revenue
20.98B
Ranking
n/a
PE Ratio
16.09
Stock Price
4,860.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 53.66B, a decrease of -42.11%. That is a compound annual growth rate of -30.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 53.66B | -27.07% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Yak I&C Co.,Ltd | 71.32B |
| BBIA Co., Ltd. | 67.20B |
| GITSN | 62.28B |
| Laseroptek | 56.78B |
| ERCOHS Agricultural Corporation Co.,Ltd | 51.03B |
| Semi Total Solution | 49.36B |
| JNB Co., Ltd. | 46.35B |
| Korea No.14 Special Purpose Acquisition | 41.48B |